ALBIREO PHARMA, INC. Zu einer Liste hinzufügen
Terminchart Albireo Pharma, Inc.
dfd04b36f31dbb0d447bfff15b7a65a.Pn_aFG3FG5KSRQXHCuP3eqwJXZYId-2VNnDEW7EXRSg.Rg_rOVTxdtCkGkagQbCjLPxmGvJ8KIfaQwn0I8JDHEcTRo5AAvZcwNszQA~9b7f648e0f439160f1d1a75d87424b97
Anstehende Termine für Albireo Pharma, Inc.
Es liegt kein Termin vor
Zurückliegende Termine für Albireo Pharma, Inc.
| 15.11.2022 11:20 | Jefferies London Healthcare Conference |
| 08.11.2022 22:30 | Q3 2022 Präsentation des Ergebnisses |
| 08.11.2022 | Q3 2022 Ergebnisveröffentlichung Nachbörslich |
| 07.11.2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37254 |
| 07.11.2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37608 |
| 07.11.2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 850 |
| 07.11.2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37939 |
| 07.11.2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 37273 |
| 06.11.2022 20:10 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Number : 865 |
| 06.11.2022 19:00 | American Association for the Study of Liver Diseases The Liver Meeting - Abstract Meeting : 37733 |
| 18.10.2022 16:30 | H.C. Wainwright Hepatitis B Virus (HBV) Conference |
| 15.10.2022 20:00 | NASPGHAN Meeting |
| 15.10.2022 18:00 | NASPGHAN Meeting - Abstract Number : 547 |
| 14.10.2022 19:45 | NASPGHAN Meeting |
| 14.10.2022 18:00 | NASPGHAN Meeting - Abstract Number : 301 |
| 13.10.2022 23:00 | NASPGHAN Meeting - Abstract Number : 70 |
| 11.10.2022 14:30 | Bylvay Phase 3 Trial Results Call |
| 28.09.2022 14:30 | Guggenheim Therapeutics Conference |
| 13.09.2022 14:30 | Baird Global Healthcare Conference |
| 12.09.2022 16:30 | Morgan Stanley Global Healthcare Conference |
Mehr Termine
